Global Stem Cell Drug Market Size, Share and Trends Analysis Report, By Product (Cord Blood-Derived, Adipose-Derived, Bone Marrow-Derived, and Others), By Application (Acute Graft-versus-Host Disease, Crohn’s Disease, Amyotrophic Lateral Sclerosis, Osteoarthritis, and Others), Forecast (2022-2028)

The global stem cell drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor expected to drive the market growth is the rising burden of chronic diseases along with the increasing investment in the R&D for stem cell researches. Furthermore, increasing demand for stem cell-based therapies has accelerated the need for innovation and development of the product are some factors that propel the growth of the stem cells drug market during the forecast period. According to the World Health Organization (WHO), there is a 57% increment in chronic disease in 2020. This, in turn, is driving the demand for stem cell drugs.

Some major players in the market include Takeda Pharmaceutical Co., Ltd., Juno Therapeutics, Inc. (Bristol-Myers Squibb Co.), and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2020, Baylx Inc. announced that the company received approval from the United States Food and Drug Administration (USFDA) for the investigational new drug (IND) umbilical cord mesenchymal stem cells product. Additionally, in May 2020, Celavie Biosciences, LLC announced that the company is developing regenerative stem cell therapies for treating central nervous system disorders and Parkinson’s disease. The company also released successful results for their clinical trial of OK99 stem cells for Parkinson’s disease.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape- Takeda Pharmaceutical Co., Ltd., Juno Therapeutics, Inc. (Bristol-Myers Squibb Co.), and Novartis International AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Stem Cell Drug Market Report by Segment

By Product

• Cord Blood-Derived
• Adipose-Derived
• Bon Marrow-Derived
• Others

By Application

• Acute Graft-versus-Host Disease
• Crohn’s Disease
• Amyotrophic Lateral Sclerosis
• Osteoarthritis
• Others

Global Stem Cell Drug Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa